
Persist AI is a pharmaceutical development company that accelerates the discovery and manufacturing of life-saving drugs. They leverage a combination of AI, robotics, and automation to optimize formulation development, aiming to reduce the time and cost associated with bringing drugs to market. Their services include a Cloud Lab for remote experiment execution, Formulation Development, Commercial cGMP Manufacturing, and Analytical Support. The company was founded with a mission to improve patient outcomes by delivering drugs faster and with fewer side effects, inspired by personal experiences with chronic conditions. Persist AI has garnered support from notable investors and accelerators like YCombinator, Innospark, and 2048 Ventures.

Persist AI is a pharmaceutical development company that accelerates the discovery and manufacturing of life-saving drugs. They leverage a combination of AI, robotics, and automation to optimize formulation development, aiming to reduce the time and cost associated with bringing drugs to market. Their services include a Cloud Lab for remote experiment execution, Formulation Development, Commercial cGMP Manufacturing, and Analytical Support. The company was founded with a mission to improve patient outcomes by delivering drugs faster and with fewer side effects, inspired by personal experiences with chronic conditions. Persist AI has garnered support from notable investors and accelerators like YCombinator, Innospark, and 2048 Ventures.
Founded: 2022
Headquarters: West Sacramento, California
Focus: AI-driven robotic high-throughput drug formulation and long-acting injectable (LAI) technologies
Platform: Persist Cloud Lab (AI + robotic experimentation)
Recent funding: Series A reported Mar 19, 2025 (~$12M)
Pharmaceutical formulation discovery and manufacturing, specifically long-acting injectable formulations.
2022
Biotechnology
4000000
Reported seed round Apr 12, 2023 (source summary lists $4M seed); company press release cites $4M seed led by 2048 Ventures.
12000000
Series A announced Mar 19, 2025 (reported $12M)
“2048 Ventures, Spero Ventures, Y Combinator, Innospark Ventures, Fellows Fund, Pioneer Fund, Jovono, and additional investors listed across rounds”